TenVaarwerk I A, Jessurun G A, DeJongste M J, Andersen C, Mannheimer C, Eliasson T, Tadema W, Staal M J
Department of Cardiology, Thoraxcenter, University Hospital of Groningen, PO Box 30,001, 9700 RB Groningen, The Netherlands.
Heart. 1999 Jul;82(1):82-8. doi: 10.1136/hrt.82.1.82.
To determine morbidity and mortality characteristics in patients treated with electrical neuromodulation for refractory angina pectoris.
A retrospective multicentre study of patients treated with spinal cord stimulation between 1987 and 1997; 21 centres were contacted and 14 responded.
Specialist centres worldwide.
Questionnaires were returned on 517 patients, of whom 71% were male. One was lost to follow up. Mean (SD) age was 63.9 (10.1) years. Duration of angina pectoris was 8.1 (6.3) years.
Before spinal cord stimulation, 66% of the patients had experienced myocardial infarction, 68% had three vessel disease, and in 24% the left ventricular ejection fraction (LVEF) was </= 40%. Percutaneous transluminal coronary angioplasty and bypass surgery were performed in 17% and 58% of the subjects, respectively. During a median follow up of 23 months (range 0 to 128), 103 patients died (52 from a cardiac cause, 25 from a non-cardiac cause, and 26 from an unknown cause). Annual all cause mortality was 7-8%; annual cardiovascular fatality was 3.5-5%. Mortality was univariately related to sex, number of diseased vessels, number of revascularisation procedures, previous myocardial infarction, LVEF, insulin dependent diabetes, beta blocking agents, and angiotensin converting enzyme inhibitors. Multiple variate analysis showed that LVEF, sex, beta blockers, and age >/= 71 years were independent predictors of mortality. During spinal cord stimulation, New York Heart Association functional class improved from 3.5 to 2.1 (p < 0.01); 25 of the deceased patients (24%) and 32 survivors (8%) experienced myocardial infarction; hospital admissions were significantly (p < 0.001) more common in the deceased group (66% v 37%).
The clinical outcome of patients with intractable angina is not adversely affected by the chronic use of neurostimulation.
确定接受电神经调节治疗难治性心绞痛患者的发病率和死亡率特征。
对1987年至1997年间接受脊髓刺激治疗的患者进行的一项回顾性多中心研究;联系了21个中心,14个中心做出了回应。
全球的专科中心。
共收到517例患者的问卷回复,其中71%为男性。1例失访。平均(标准差)年龄为63.9(10.1)岁。心绞痛病程为8.1(6.3)年。
在进行脊髓刺激之前,66%的患者曾发生过心肌梗死,68%的患者有三支血管病变,24%的患者左心室射血分数(LVEF)≤40%。分别有17%和58%的受试者接受了经皮腔内冠状动脉成形术和搭桥手术。在中位随访23个月(范围0至128个月)期间,103例患者死亡(52例死于心脏原因,25例死于非心脏原因,26例死因不明)。年全因死亡率为7%-8%;年心血管死亡率为3.5%-5%。死亡率单因素与性别、病变血管数量、血运重建手术次数、既往心肌梗死、LVEF、胰岛素依赖型糖尿病、β受体阻滞剂和血管紧张素转换酶抑制剂有关。多变量分析显示,LVEF、性别、β受体阻滞剂和年龄≥71岁是死亡率的独立预测因素。在脊髓刺激期间,纽约心脏协会功能分级从3.5改善至2.1(p<0.01);25例死亡患者(24%)和32例存活患者(8%)发生了心肌梗死;死亡组的住院率明显更高(p<0.001)(66%对37%)。
长期使用神经刺激对难治性心绞痛患者的临床结局没有不利影响。